Aspiriant LLC’s Sanofi SNY Stock Holding History

Aspiriant LLC’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,070	Closed	-$243K	–	260
2018 Q1	$243K	Buy	+6,070	New	+$253K	0.02%	214

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Aspiriant LLC's SNY Position: Q2 2018 in Review

Aspiriant LLC sold out of Sanofi (SNY) in Q2 2018, closing a stake of 6,070 shares — an estimated $243K sold.

Aspiriant LLC first reported a position in SNY in Q1 2018 and held it in 1 quarter. The position peaked at $243K in Q1 2018. 478 funds tracked by Wall St. Rank hold SNY as of Q2 2018.

Aspiriant LLC reported no remaining Sanofi position as of Q2 2018 after selling out during the quarter.
Aspiriant LLC sold 6,070 Sanofi shares in Q2 2018, an estimated $243K.
Aspiriant LLC first reported a position in Sanofi in Q1 2018 and held it in 1 quarter.
Aspiriant LLC's Sanofi position peaked at $243K in Q1 2018.
478 funds tracked by Wall St. Rank held Sanofi as of Q2 2018.

Based on Aspiriant LLC's 13F filing for Q2 2018, filed 7 Aug 2018.